BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 13, 2019
View Archived Issues
Role of p300 in BRD4-NUT-driven NUT carcinomas and novel dual BET/p300 bromodomain inhibitors
Read More
MAb targeting TREM1+ myeloid cells boosts antitumor immunity and checkpoint inhibitor sensitivity
Read More
Prelude initiates phase I study of PRT-811 in advanced solid tumors, gliomas and myelofibrosis
Read More
Encouraging results seen in phase II studies of NanoPac paclitaxel
Read More
Corcept initiates phase II study of miricorilant for antipsychotic-induced weight gain
Read More
Small-molecule STING agonist promotes durable antitumor immunity causing complete tumor regression
Read More
Case study points to protective AD gene
Read More
RNA controls muscle stem cells
Read More
24-week data presented from HMM0301 phase III monotherapy study of dorzagliatin
Read More
FDA approves IND for WP-1066
Read More
FDA places on hold the phase I/II IGNITE DMD study of SGT-001
Read More
New data presented for ParvOryx in human ovarian cancer explants
Read More
DCC-3116 as a promising inhibitor of autophagy in preclinical models of RAS-mutant cancers
Read More
Preclinical and preliminary first-in-human data presented for STRO-002
Read More
Chugai Pharmaceuticals presents phase I data for EOS-789
Read More
SentiBio presents novel allogenic cell therapy, SENTI-101
Read More
KD-025 meets primary endpoint at interim analysis of pivotal ROCKstar study in chronic GvHD
Read More
Positive data presented from initial cohort of phase IIb study of ORMD-0801 in T2D
Read More
Virginia Tech Intellectual Properties describes mitochondrial uncouplers
Read More
Celgene patents compounds for diffuse large B-cell lymphoma
Read More
Macrocyclic oligopeptides identified at Roche
Read More
Vertex, Merck & Co. describe endoplasmic reticulum stress inducers
Read More
New P2X7 receptor antagonists identified at Shionogi
Read More
Break out the sparkling apple cider for DUR-928 alcoholic hepatitis data
Read More
New exploratory phase I/II study in Japan assesses NS-089 in Duchenne muscular dystrophy
Read More
Bellerophon reports initial data from acute hemodynamic study of INOpulse
Read More
